Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer
Conditions
- Advanced Epithelial Ovarian Cancer
Interventions
- DRUG: Carboplatin/paclitaxel
Sponsor
Cairo University
Collaborators